Table 6 Outcome of the low-risk CBF AML study population by GO treatment received

GO (n = 52)

 CIR

  Median, years

5.1

3.2

5.6

   10 years

28.1

14.9–39.2

40.4

16–57.7

21.4

4.2–32.2

0.13

 OS

  Median, years

5.8

5.4

5.8

   10 years

88.6

80.4–97.6

90.5

78.8–100

86.5

75.1–99.7

0.66

No-GO (n = 51)

 CIR

  Median, years

4.8

1.1

5.2

   10 years

39.8

26.2–53.1

58.6

32.3–77.6

28.9

14.2–45.4

0.01

 OS

  Median, years

5.4

5.8

5.4

   10 years

80.1

69.8–91.9

78.9

62.6–99.6

83.5

71.2–97.8

0.69